ARTICLE | Distillery Therapeutics
Cancer
May 23, 2017 8:34 PM UTC
Cell culture studies suggest inhibiting PRKCD, PKCE or RASGRP3 could help treat GNAQ-mutant uveal melanoma. Levels of RASGRP3 were higher in five human GNAQ-mutant uveal melanoma cell lines than in fo...